Choose language
Do you want to set the chosen language as default?
Yes, set as default
Search
Trending Topics
Stock

Apple

 Stock

Intel

 Stock

SpaceX

 Stock

Accenture

 Crypto

Bitcoin

 Asset

ETFs

Stocks

See all

ETFs

See all

Cryptocurrencies

See all

Tools

Price

$1.28

return (12m)

-91.60% Logo

p/e

-0.31

p/bv

0.51

DIVIDEND YIELD

0.00%
graph

ENVB price

Select period
Select period
Enveric Biosciences
If you had invested
If you had invested
exposure
years ago
7 days
30 days
6 months
YTD
1 year
5 years
10 years
15 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.

Return on Investment ENVB

1 month
3 months
1 year
2 years
5 years
10 years
return
1 month
-42.08%
3 months
-36.00%
1 year
-91.60%
2 years
-98.84%
5 years
-99.99%
10 years
-100.00%
Estatistica

Fundamentals ENVB

review the fundamentals of Enveric Biosciences shares

P/E

-0.31
Sector: -2.09 Industry: -5.41

P/S (PSR)

-
Sector: 1.96 Industry: 3.06

P/BV

0.51
Sector: 2.11 Industry: 1.91

DIVIDEND YIELD (DY)

0.00%
Sector: - Industry: -

ROA

-148.73%
Sector: -27.28% Industry: -48.67%

ROE

-162.25%
Sector: -32.48% Industry: -44.90%

ROIC

-4,214.19%
Sector: -444.34% Industry: -542.40%

NET MARGIN

0.00%
Sector: -29.63% Industry: -36.04%

GROSS MARGIN

0.00%
Sector: 44.85% Industry: 48.01%

OPERATING MARGIN

0.00%
Sector: -24.54% Industry: -31.89%

EV/EBITDA

-0.32
Sector: -0.22 Industry: -3.07

EV/EBIT

-0.31
Sector: -1.81 Industry: -5.09

PRICE-TO-ASSETS

0.46
Sector: 1.17 Industry: 1.28

BVPS

2.53
Sector: 3.85 Industry: 2.07

EPS

-4.11
Sector: -0.89 Industry: -1.24

EQUITY-TO-ASSETS RATIO

0.92
Sector: 0.43 Industry: 0.48

LIABILITIES / ASSETS

0.08
Sector: 0.47 Industry: 0.43

CAGR REVENUE 5 YEARS

0.00%
Sector: - Industry: -

CAGR PROFIT 5 YEARS

-30.03%
Sector: - Industry: -
statistics

Fundamentals ENVB

Buy And Hold Investor Checklist

Enveric Biosciences Buy And Hold Investor Checklist


This checklist is for informational purposes only and does not constitute investment advice or a recommendation. The score is based on current market parameters and does not guarantee future performance. [Learn how the scoring system works.]

Stock Comparison Tool

graph

Stock vs Indice Comparison Tool

If you had invested
If you had invested
years ago
2 years
5 years
10 years
ago, you would now have *
ago, you would now have:
*
*This calculation reflects price variation only.
Price

ENVB Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

ABOUT

Logo Enveric Biosciences

Enveric Biosciences Inc.

Average Investor10 user rating

4.0 (0 people)

United States

United States

32 years

Founded: 1994

1995

Time since IPO - 31 years

3

Employees

Market cap

$2.56 million

$2.56 million

Net worth

$5.06 million

$5,060,000.00

Assets

$5.52 million

$5,520,000.00

Total Shares Outstanding

2.00 million

2,000,000

Average Daily Trading Volume

$4.84 million

$4,836,028.00

Sector

Health

Industry

Pharmaceutical Products

Shares

ENVB
receitas e lucros

ENVB revenue and profits

graph

PROFIT X PRICE ENVB

resultados

Financial Results ENVB

DRAG THE FRAME TO SEE MORE DATA
Resultados

ENVB cash flow

DRAG THE FRAME TO SEE MORE DATA
Ativos e Passivos

Asset, Revenue and Profit Growth - ENVB

Pontos Relevantes

ENVB balance sheet

DRAG THE FRAME TO SEE MORE DATA
Discover more assets
Logo CVS Health

CVS - CVS Health

$98.32 53,08% (12M)
P/E

42.69

DY

2.71%

ROE

3.78%

P/BV

1.61
Logo Cigna

CI - Cigna

$279.27 --9,20% (12M)
P/E

11.36

DY

2.20%

ROE

15.39%

P/BV

1.75
Logo Centene

CNC - Centene

$61.02 12,17% (12M)
P/E

-4.66

DY

0.00%

ROE

-29.93%

P/BV

1.39
Logo Humana

HUM - Humana

$360.65 53,26% (12M)
P/E

38.30

DY

0.98%

ROE

6.06%

P/BV

2.32
Logo Sanofi

SNY - Sanofi

$42.38 --7,96% (12M)
P/E

6.93

DY

4.17%

ROE

17.79%

P/BV

1.23
Logo Eli Lilly

LLY - Eli Lilly

$1,098.57 43,57% (12M)
P/E

38.90

DY

0.59%

ROE

81.02%

P/BV

31.52
Logo HCA Healthcare

HCA - HCA Healthcare

$375.17 0,23% (12M)
P/E

12.37

DY

0.78%

ROE

-228.14%

P/BV

-28.22
Logo Novartis

NVS - Novartis

$147.09 29,52% (12M)
P/E

20.75

DY

2.11%

ROE

34.77%

P/BV

7.21
Logo CVS Health

CVS - CVS Health

$98.32 53,08% (12 M)
P/L

42.69

DY

2.71%

ROE

3.78%

P/VP

1.61
Logo Cigna

CI - Cigna

$279.27 --9,20% (12 M)
P/L

11.36

DY

2.20%

ROE

15.39%

P/VP

1.75
Logo Centene

CNC - Centene

$61.02 12,17% (12 M)
P/L

-4.66

DY

0.00%

ROE

-29.93%

P/VP

1.39
Logo Humana

HUM - Humana

$360.65 53,26% (12 M)
P/L

38.30

DY

0.98%

ROE

6.06%

P/VP

2.32
Logo Sanofi

SNY - Sanofi

$42.38 --7,96% (12 M)
P/L

6.93

DY

4.17%

ROE

17.79%

P/VP

1.23
Logo Eli Lilly

LLY - Eli Lilly

$1,098.57 43,57% (12 M)
P/L

38.90

DY

0.59%

ROE

81.02%

P/VP

31.52
Logo HCA Healthcare

HCA - HCA Healthcare

$375.17 0,23% (12 M)
P/L

12.37

DY

0.78%

ROE

-228.14%

P/VP

-28.22
Logo Novartis

NVS - Novartis

$147.09 29,52% (12 M)
P/L

20.75

DY

2.11%

ROE

34.77%

P/VP

7.21

Frequently Asked Questions

What is the price of Enveric Biosciences (ENVB) today?

The current price of Enveric Biosciences (ENVB) is $1.28. The stock began the year trading around $3.63 and is currently priced at $1.28. You can follow the real-time price chart, review historical performance, and track broader market trends directly on the platform.

When does Enveric Biosciences (ENVB) pay dividends?

Enveric Biosciences (ENVB) did not pay dividends over the past year.

Is Enveric Biosciences (ENVB) a good investment?

Enveric Biosciences (ENVB) is currently trading at $1.28 with a P/E ratio of -0.31. This represents a -15% premium compared to its historical average P/E. Over the past year, the stock paid $0.00 in dividends, resulting in a dividend yield of 0.00%. The total shareholder return over the same period was -91.60%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Enveric Biosciences (ENVB) stock?

You can buy Enveric Biosciences (ENVB) shares through any brokerage account that provides access to U.S. stock exchanges. After opening and funding your account, simply search for the ticker symbol ENVB and place a buy order. Before investing, consider factors such as your financial goals, risk tolerance, and overall portfolio allocation.

How much would 100 shares of Enveric Biosciences (ENVB) yield today?

Over the past month, Enveric Biosciences (ENVB) has returned -42.08% — -91.60% over the past year, and -99.99% over the past five years, including price appreciation and dividends.

In the last 12 months, the company paid a total of 0.00 per share in dividends, resulting in a dividend yield of 0.00%.

If you were to purchase 100 shares of Enveric Biosciences (ENVB) today at the current price of $1.28 your total investment would be $128.00.

Based on historical performance, the investment would have grown to approximately:

  • $10.75 after 1 year
  • $0.01 after 5 years
  • $0.00 after 10 years

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.